Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hypersensitivity Pneumonitis: early-phase trial registry
3 of 4 indexed Hypersensitivity Pneumonitis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Hypersensitivity Pneumonitis: 4 US clinical trials tracked, 3 recruiting.
Hypersensitivity Pneumonitis is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is National Jewish Health, running 1 of these trials.
Enrollment posture brief
Registry condition hypersensitivity-pneumonitis
OPEN 3 | RECR 75% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Hypersensitivity Pneumonitis lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hypersensitivity Pneumonitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hypersensitivity Pneumonitis is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Interstitial Lung Disease Research Unit Biobank
University of Kansas Medical Center
NCT05392881
Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis
Weill Medical College of Cornell University
NCT06811389
FAPI PET for Lung Fibrosis
University of California, Los Angeles
NCT05365802
A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
National Jewish Health
NCT04844359
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hypersensitivity Pneumonitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hypersensitivity Pneumonitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hypersensitivity Pneumonitis page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Hypersensitivity Pneumonitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Jewish Health sponsors the most Hypersensitivity Pneumonitis trials on record, review their full trial history before evaluating a specific study. See National Jewish Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypersensitivity Pneumonitis condition card totals 4 registered trials; most-linked intervention High Resolution Computed Tomography; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.